X Financial shares are trading lower after the company reported disappointing Q4 financial results, with net income decreasing by 85.2% year-over-year due to higher provisioning and lower loan facilitation revenue.

Journey Medical shares are trading lower after the company reported a net loss of $11.4 million for FY2025 despite an increase in revenue, due to competitive pressures and a rise in selling, general, and administrative expenses.

SeaStar Medical shares are trading higher after the company reported progress in clinical trials and financial improvements, including significant enrollment milestones in its NEUTRALIZE-AKI trial and a notable increase in revenue.

Addentax Group Corp. shares are trading lower after the company announced a 1-for-15 reverse stock split, raising concerns about the company's future financial performance.

Pulmatrix shares are trading lower due to uncertainties surrounding its proposed merger with Eos SENOLYTIX, which involves complex financial and regulatory conditions that have yet to be fully resolved.

Worthington Steel shares are trading lower after the company reported a significant drop in operating income for the fiscal third quarter of 2026, largely due to increased SG&A expenses and lower toll volumes.

Cibus shares are trading lower after the company announced a public offering of Class A Common Stock and pre-funded warrants.

Firefly Neuroscience shares are trading higher after announcing a strategic partnership with the Department of War to deploy its AI-powered, FDA-cleared EEG/ERP technology in the assessment and treatment of PTSD and TBI in U.S. service members.

GCT Semiconductor shares are trading lower after the company reported a significant net loss and lower revenues for the fourth quarter and full year 2025, reflecting substantial investments in 5G technologies.

22nd Century Group shares are trading higher after the company reported its fourth quarter and fiscal year 2025 financial results, highlighting strategic focus on expanding high-margin VLN product lines and exiting the year with no outstanding debt.

Soligenix shares are trading higher after the company received European Orphan Drug Designation for SGX945 in the treatment of Behçet's Disease.

The Lovesac Company shares are trading higher after the company announced an expansion of its share repurchase authorization by $40 million, increasing the total repurchase amount to approximately $54 million, reflecting strong confidence in its business outlook.

Designer Brands Inc. shares are trading lower after the company reported a net loss of $20.0 million for the fourth quarter, reflecting a decrease in total comparable sales and a decline in annual net sales.

Noodles & Company shares are trading higher after the company announced a significant increase in comparable restaurant sales, with a system-wide growth of 6.6% in Q4 2025 and over 9% to date in Q1 2026.

Rockwell Medical shares are trading lower after the company reported a significant decline in net sales for 2025, driven by reduced purchase volumes from major customers and resulting in increased annual net losses.

Kodiak Sciences shares are trading higher after the company announced positive topline results from its GLOW2 Phase 3 study, demonstrating the superiority of Zenkuda over sham in diabetic retinopathy treatment.

Immutep Ltd. shares are trading higher despite recent legal challenges surrounding alleged securities fraud related to their TACTI-004 oncology trial.

Edible Garden shares are trading higher after announcing a strategic partnership with Steadfast City Economic & Community Partners to develop a Farm-to-Formula® Ready-to-Drink Midwest Tetra Pak platform.

MillerKnoll shares are trading lower after the company reported its third-quarter fiscal 2026 results.

Onconetix shares are trading higher after the company highlighted Realbotix's key role in Ericsson's world-first 6G trial, amid its pending acquisition of Realbotix LLC.